Su253 DEVELOPMENT AND VALIDATION OF A NOVEL MORTALITY RISK SCORE THAT INCLUDES USE OF ANTITHROMBOTICS IN PATIENTS WITH OVERT GASTROINTESTINAL BLEEDING
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI